MedTrace Logo

Effects of Chicken Protein Hydrolysate (CPH) Supplementation in People With High Waist Circumference

NCT05149092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2023-11-29

No results posted yet for this study

Summary

In this randomized, placebo controlled, double blind trial, effects of relatively high doses of chicken protein hydrolysate (CPH) or casein hydrolysate (placebo) supplementation will be investigate in healthy persons with abdominal obesity. The 12-week study examines potential effects on body weight, abdominal obesity, body composition, plasma parameters of metabolic health including lipids, inflammatory parameters, redox state and microbiota biomarkers.

Conditions

  • Abdominal Obesity

Interventions

DIETARY_SUPPLEMENT

Chicken protein hydrolysate supplement

Daily oral self-administration of 18 g of supplement dissolved in water/mineral water, spread over 2-3 occasions

DIETARY_SUPPLEMENT

Placebo

Daily oral self-administration of 18 g of supplement dissolved in water/mineral water, spread over 2-3 occasions

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • Norilia AS

    collaborator UNKNOWN

  • University of Bergen

    lead OTHER

Principal Investigators

  • Rolf K Berge, PhD · University of Bergen, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05149092 on ClinicalTrials.gov